{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:12:31Z","timestamp":1790655151294,"version":"4.1.0"},"reference-count":169,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T00:00:00Z","timestamp":1696809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Inflammatory bowel diseases (IBDs) are chronic, relapsing inflammatory disorders of the gastrointestinal tract, frequently associated with extraintestinal manifestations (EIMs) that can severely affect IBD patients\u2019 quality of life, sometimes even becoming life-threatening. Respiratory diseases have always been considered a rare and subsequently neglected extraintestinal manifestations of IBD. However, increasing evidence has demonstrated that respiratory involvement is frequent in IBD patients, even in the absence of respiratory symptoms. Airway inflammation is the most common milieu of IBD-related involvement, with bronchiectasis being the most common manifestation. Furthermore, significant differences in prevalence and types of involvement are present between Crohn\u2019s disease and ulcerative colitis. The same embryological origin of respiratory and gastrointestinal tissue, in addition to exposure to common antigens and cytokine networks, may all play a potential role in the respiratory involvement. Furthermore, other causes such as drug-related toxicity and infections must always be considered. This article aims at reviewing the current evidence on the association between IBD and respiratory diseases. The purpose is to raise awareness of respiratory manifestation among IBD specialists and emphasize the need for identifying respiratory diseases in early stages to promptly treat these conditions, avoid worsening morbidity, and prevent lung damage.<\/jats:p>","DOI":"10.3390\/jcm12196419","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T10:48:33Z","timestamp":1696848513000},"page":"6419","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Lung Involvement in Inflammatory Bowel Diseases: Shared Pathways and Unwanted Connections"],"prefix":"10.3390","volume":"12","author":[{"given":"Carolina Aliai Micol","family":"Cavalli","sequence":"first","affiliation":[{"name":"IBD Center, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy"},{"name":"Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20072 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Gabbiadini","sequence":"additional","affiliation":[{"name":"IBD Center, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8543-4355","authenticated-orcid":false,"given":"Arianna","family":"Dal Buono","sequence":"additional","affiliation":[{"name":"IBD Center, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Quadarella","sequence":"additional","affiliation":[{"name":"IBD Center, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy"},{"name":"Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20072 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"De Marco","sequence":"additional","affiliation":[{"name":"IBD Center, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy"},{"name":"Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20072 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Repici","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20072 Milan, Italy"},{"name":"Division of Gastroenterology and Digestive Endoscopy, Department of Gastroenterology, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Bezzio","sequence":"additional","affiliation":[{"name":"IBD Center, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy"},{"name":"Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20072 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Simonetta","sequence":"additional","affiliation":[{"name":"Respiratory Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Aliberti","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20072 Milan, Italy"},{"name":"Respiratory Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1572-0118","authenticated-orcid":false,"given":"Alessandro","family":"Armuzzi","sequence":"additional","affiliation":[{"name":"IBD Center, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy"},{"name":"Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20072 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,10,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41572-020-0156-2","article-title":"Crohn\u2019s Disease","volume":"6","author":"Roda","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","article-title":"Ulcerative Colitis","volume":"6","author":"Kobayashi","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrgastro.2017.136","article-title":"Environmental Triggers in IBD: A Review of Progress and Evidence","volume":"15","author":"Ananthakrishnan","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"7247238","DOI":"10.1155\/2019\/7247238","article-title":"A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease","volume":"2019","author":"Guan","year":"2019","journal-title":"J. Immunol. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/ecco-jcc\/jjv213","article-title":"The First European Evidence-Based Consensus on Extra-Intestinal Manifestations in Inflammatory Bowel Disease","volume":"10","author":"Harbord","year":"2016","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Gordon, H., Burisch, J., Ellul, P., Karmiris, K., Katsanos, K., Allocca, M., Bamias, G., Barreiro-de Acosta, M., Braithwaite, T., and Greuter, T. (2023). ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease. J. Crohn\u2019s Colitis.","DOI":"10.1093\/ecco-jcc\/jjad108"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/00054725-200303000-00004","article-title":"Pulmonary Manifestations of Inflammatory Bowel Disease","volume":"9","author":"Storch","year":"2003","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1097\/MIB.0000000000000392","article-title":"Extraintestinal Manifestations of Inflammatory Bowel Disease","volume":"21","author":"Vavricka","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1007\/s10620-022-07385-z","article-title":"Prevalence of Pulmonary Diseases in Association with Inflammatory Bowel Disease","volume":"67","author":"Pemmasani","year":"2022","journal-title":"Dig. Dis. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/mi.2011.55","article-title":"Pulmonary-Intestinal Cross-Talk in Mucosal Inflammatory Disease","volume":"5","author":"Keely","year":"2012","journal-title":"Mucosal Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Schmid, F., Chao, C.-M., and D\u00e4britz, J. (2022). Pathophysiological Concepts and Management of Pulmonary Manifestation of Pediatric Inflammatory Bowel Disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23137287"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/gut.50.3.307","article-title":"Augmented Increase in Tight Junction Permeability by Luminal Stimuli in the Non-Inflamed Ileum of Crohn\u2019s Disease","volume":"50","author":"Soderholm","year":"2002","journal-title":"Gut"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/gutjnl-2012-303207","article-title":"Bacteria Penetrate the Normally Impenetrable Inner Colon Mucus Layer in Both Murine Colitis Models and Patients with Ulcerative Colitis","volume":"63","author":"Johansson","year":"2014","journal-title":"Gut"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1700931","DOI":"10.1002\/mnfr.201700931","article-title":"Human Intestinal Dendritic Cells in Inflammatory Bowel Diseases","volume":"62","author":"Bernardo","year":"2018","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMra052723","article-title":"The Many Roles of Chemokines and Chemokine Receptors in Inflammation","volume":"354","author":"Charo","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/imm.12114","article-title":"Circulating CD4+ and CD8+ T Cells Are Activated in Inflammatory Bowel Disease and Are Associated with Plasma Markers of Inflammation","volume":"140","author":"Funderburg","year":"2013","journal-title":"Immunology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1053\/j.gastro.2008.09.064","article-title":"VEGF-A Links Angiogenesis and Inflammation in Inflammatory Bowel Disease Pathogenesis","volume":"136","author":"Scaldaferri","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/00042737-200505000-00012","article-title":"Quantitative Measurement of Cytokine MRNA in Inflammatory Bowel Disease: Relation to Clinical and Endoscopic Activity and Outcome","volume":"17","author":"Raddatz","year":"2005","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1189\/jlb.3RU1114-563R","article-title":"Potential Mechanisms Regulating Pulmonary Pathology in Inflammatory Bowel Disease","volume":"98","author":"Mateer","year":"2015","journal-title":"J. Leukoc. Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"L134","DOI":"10.1152\/ajplung.00050.2004","article-title":"VEGF Causes Pulmonary Hemorrhage, Hemosiderosis, and Air Space Enlargement in Neonatal Mice","volume":"287","author":"Spitzmiller","year":"2004","journal-title":"Am. J. Physiol.-Lung Cell. Mol. Physiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1164\/ajrccm\/136.1.9","article-title":"The Pulmonary Vascular Sequestration of Neutrophils in Endotoxemia Is Initiated by an Effect of Endotoxin on Neutrophil in the Rabbit","volume":"136","author":"Haslett","year":"1987","journal-title":"Am. Rev. Respir. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1164\/ajrccm\/143.5_Pt_1.1083","article-title":"Differential Activation of Mixed Venous and Arterial Neutrophils in Patients with Sepsis Syndrome and Acute Lung Injury","volume":"143","author":"Nahum","year":"1991","journal-title":"Am. Rev. Respir. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00054725-200111000-00001","article-title":"Chemokine Receptor CXCR3 Expression in Inflammatory Bowel Disease","volume":"7","author":"Yuan","year":"2001","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/1521-4141(200003)30:3<819::AID-IMMU819>3.0.CO;2-Y","article-title":"Human Intestinal Lamina Propria and Intraepithelial Lymphocytes Express Receptors Specific for Chemokines Induced by Inflammation","volume":"30","author":"Agace","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1084\/jem.20122762","article-title":"Lung Dendritic Cells Induce Migration of Protective T Cells to the Gastrointestinal Tract","volume":"210","author":"Ruane","year":"2013","journal-title":"J. Exp. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/gutjnl-2012-303252","article-title":"Collagen Degradation and Neutrophilic Infiltration: A Vicious Circle in Inflammatory Bowel Disease","volume":"63","author":"Koelink","year":"2014","journal-title":"Gut"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"7735","DOI":"10.3748\/wjg.v22.i34.7735","article-title":"Inflammatory Bowel Disease and Airway Diseases","volume":"22","author":"Vutcovici","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/ajg.2011.19","article-title":"The Prognostic Power of the NOD2 Genotype for Complicated Crohn\u2019s Disease: A Meta-Analysis","volume":"106","author":"Adler","year":"2011","journal-title":"Am. J. Gastroenterol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1440-1843.2011.02069.x","article-title":"A NOD2 Gene Polymorphism Is Associated with the Prevalence and Severity of Chronic Obstructive Pulmonary Disease in a Japanese Population","volume":"17","author":"Kinose","year":"2012","journal-title":"Respirology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1007\/s00018-012-1246-4","article-title":"Muramyl Dipeptide Responsive Pathways in Crohn\u2019s Disease: From NOD2 and Beyond","volume":"70","author":"Salem","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/gut.2009.206466","article-title":"Crohn\u2019s Disease: NOD2, Autophagy and ER Stress Converge","volume":"60","author":"Fritz","year":"2011","journal-title":"Gut"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1136\/gut.2003.032805","article-title":"NOD2 (CARD15) Mutations in Crohn\u2019s Disease Are Associated with Diminished Mucosal -Defensin Expression","volume":"53","author":"Wehkamp","year":"2004","journal-title":"Gut"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1136\/gut.2009.199679","article-title":"New IBD Genetics: Common Pathways with Other Diseases","volume":"60","author":"Lees","year":"2011","journal-title":"Gut"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00005792-199372030-00003","article-title":"The Lung in Inflammatory Bowel Disease","volume":"72","author":"Camus","year":"1993","journal-title":"Medicine"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"W452","DOI":"10.2214\/AJR.10.5353","article-title":"Thoracic Manifestations of Inflammatory Bowel Disease","volume":"197","author":"Betancourt","year":"2011","journal-title":"Am. J. Roentgenol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/thx.35.8.581","article-title":"Bronchial Disease in Ulcerative Colitis","volume":"35","author":"Higenbottam","year":"1980","journal-title":"Thorax"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"560","DOI":"10.4291\/wjgp.v5.i4.560","article-title":"Patterns of Airway Involvement in Inflammatory Bowel Diseases","volume":"5","author":"Papanikolaou","year":"2014","journal-title":"World J. Gastrointest. Pathophysiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"5697846","DOI":"10.1155\/2018\/5697846","article-title":"Radiological Patterns of Lung Involvement in Inflammatory Bowel Disease","volume":"2018","author":"Cozzi","year":"2018","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"5653","DOI":"10.3748\/wjg.v18.i39.5653","article-title":"Tracheobronchial Nodules and Pulmonary Infiltrates in a Patient with Crohn\u2019s Disease","volume":"18","author":"Lu","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Plataki, M., Tzortzaki, E., Lambiri, I., Giannikaki, E., Ernst, A., and Siafakas, N.M. (2006). Severe Airway Stenosis Associated with Crohn\u2019s Disease: Case Report. BMC Pulm. Med., 6.","DOI":"10.1186\/1471-2466-6-7"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S2213-2600(21)00277-0","article-title":"Criteria and Definitions for the Radiological and Clinical Diagnosis of Bronchiectasis in Adults for Use in Clinical Trials: International Consensus Recommendations","volume":"10","author":"Aliberti","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S2213-2600(23)00093-0","article-title":"Bronchiectasis in Europe: Data on Disease Characteristics from the European Bronchiectasis Registry (EMBARC)","volume":"11","author":"Chalmers","year":"2023","journal-title":"Lancet Respir. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0140-6736(18)31767-7","article-title":"Advances in Bronchiectasis: Endotyping, Genetics, Microbiome, and Disease Heterogeneity","volume":"392","author":"Flume","year":"2018","journal-title":"Lancet"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1164\/rccm.202108-1889OC","article-title":"Characterization of Eosinophilic Bronchiectasis: A European Multicohort Study","volume":"205","author":"Shoemark","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2001702","DOI":"10.1183\/13993003.01702-2020","article-title":"Sputum Neutrophil Elastase in Bronchiectasis: A Southern European Cohort Study","volume":"56","author":"Gramegna","year":"2020","journal-title":"Eur. Respir. J."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Oriano, M., Gramegna, A., Amati, F., D\u2019Adda, A., Gaffuri, M., Contoli, M., Bindo, F., Simonetta, E., Di Francesco, C., and Santambrogio, M. (2021). T2-High Endotype and Response to Biological Treatments in Patients with Bronchiectasis. Biomedicines, 9.","DOI":"10.3390\/biomedicines9070772"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S2213-2600(20)30504-X","article-title":"Neutrophil Extracellular Traps, Disease Severity, and Antibiotic Response in Bronchiectasis: An International, Observational, Multicohort Study","volume":"9","author":"Keir","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1900303","DOI":"10.1183\/13993003.00303-2019","article-title":"A Point-of-Care Neutrophil Elastase Activity Assay Identifies Bronchiectasis Severity, Airway Infection and Risk of Exacerbation","volume":"53","author":"Shoemark","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1007\/s00384-006-0094-9","article-title":"Inflammatory Bowel Disease and the Lung: Is There a Link between Surgery and Bronchiectasis?","volume":"21","author":"Kelly","year":"2006","journal-title":"Int. J. Color. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1038\/s41424-018-0054-z","article-title":"Co-Occurrence of Asthma and the Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis","volume":"9","author":"Kuenzig","year":"2018","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1155\/2013\/102859","article-title":"Environment and the Inflammatory Bowel Diseases","volume":"27","author":"Frolkis","year":"2013","journal-title":"Can. J. Gastroenterol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s11894-013-0326-4","article-title":"The Role of the Environment in the Development of Pediatric Inflammatory Bowel Disease","volume":"15","author":"Aujnarain","year":"2013","journal-title":"Curr. Gastroenterol. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/aje\/kwu072","article-title":"Breastfeeding and Childhood Asthma: Systematic Review and Meta-Analysis","volume":"179","author":"Dogaru","year":"2014","journal-title":"Am. J. Epidemiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/ACI.0000000000000101","article-title":"The Evolution of the Hygiene Hypothesis: The Role of Early-Life Exposures to Viruses and Microbes and Their Relationship to Asthma and Allergic Diseases","volume":"14","author":"Daley","year":"2014","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2147\/ITT.S61528","article-title":"The Hygiene Hypothesis: Current Perspectives and Future Therapies","volume":"4","author":"Stiemsma","year":"2015","journal-title":"Immunotargets Ther."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1053\/gast.1996.v110.pm8613037","article-title":"Survival and Cause-Specific Mortality in Inflammatory Bowel Disease: A Population-Based Cohort Study","volume":"110","author":"Persson","year":"1996","journal-title":"Gastroenterology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.3389\/fimmu.2020.02144","article-title":"Links between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease","volume":"11","author":"Raftery","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.crohns.2010.03.008","article-title":"Pulmonary Manifestations of Inflammatory Bowel Disease: Case Presentations and Review","volume":"4","author":"Basseri","year":"2010","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1055\/s-0033-1343886","article-title":"Risk of Venous Thromboembolism in Patients with Inflammatory Bowel Disease","volume":"39","author":"Koutroumpakis","year":"2013","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1111\/j.1572-0241.2008.02052.x","article-title":"Rising Prevalence of Venous Thromboembolism and Its Impact on Mortality Among Hospitalized Inflammatory Bowel Disease Patients","volume":"103","author":"Nguyen","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jamainternmed.2013.122","article-title":"Use of Glucocorticoids and Risk of Venous Thromboembolism","volume":"173","author":"Johannesdottir","year":"2013","journal-title":"JAMA Intern. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.3748\/wjg.v26.i12.1231","article-title":"Venous Thromboembolism in Inflammatory Bowel Disease","volume":"26","author":"Cheng","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.cgh.2014.07.017","article-title":"Increased Risk of Venous Thromboembolic Events with Corticosteroid vs Biologic Therapy for Inflammatory Bowel Disease","volume":"13","author":"Higgins","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/MCG.0000000000001290","article-title":"Successful Infliximab Treatment Is Associated with Reversal of Clotting Abnormalities in Inflammatory Bowel Disease Patients","volume":"54","author":"Detrez","year":"2020","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/MCG.0000000000000408","article-title":"Antitumor Necrosis Factor-\u03b1 Therapy Is Associated with Reduced Risk of Thromboembolic Events in Hospitalized Patients with Inflammatory Bowel Disease","volume":"50","author":"Tuskey","year":"2016","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.semarthrit.2015.07.006","article-title":"Vasculitis in Patients with Inflammatory Bowel Diseases: A Study of 32 Patients and Systematic Review of the Literature","volume":"45","author":"Sy","year":"2016","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_67","first-page":"1617","article-title":"Pulmonary Manifestations of Ulcerative Colitis Mimicking Wegener\u2019s Granulomatosis","volume":"26","author":"Stebbing","year":"1999","journal-title":"J. Rheumatol."},{"key":"ref_68","first-page":"1154","article-title":"Pulmonary Function Abnormalities in Patients with Ulcerative Colitis","volume":"92","author":"Godet","year":"1997","journal-title":"Am. J. Gastroenterol."},{"key":"ref_69","first-page":"241","article-title":"Pulmonary Function Abnormalities in Patients with Inflammatory Bowel Disease","volume":"51","author":"Heatley","year":"1982","journal-title":"Q. J. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1572-0241.2002.05473.x","article-title":"Alterations in Pulmonary Function in Inflammatory Bowel Disease Are Frequent and Persist during Remission","volume":"97","author":"Herrlinger","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0953-6205(02)00097-3","article-title":"Pulmonary Function Abnormalities in Respiratory Asymptomatic Patients with Inflammatory Bowel Disease","volume":"13","author":"Mohr","year":"2002","journal-title":"Eur. J. Intern. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/ecco-jcc\/jjab024","article-title":"Subclinical Pulmonary Involvement in Active IBD Responds to Biologic Therapy","volume":"15","author":"Ellrichmann","year":"2021","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3892\/mi.2022.50","article-title":"Role of Pulmonary Function Testing in Inflammatory Bowel Diseases (Review)","volume":"2","author":"Georgakopoulou","year":"2022","journal-title":"Med. Int."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"13501","DOI":"10.3748\/wjg.v20.i37.13501","article-title":"Pulmonary Manifestations of Inflammatory Bowel Disease","volume":"20","author":"Ji","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00004836-200310000-00006","article-title":"Pulmonary Function Tests and High-Resolution CT in the Detection of Pulmonary Involvement in Inflammatory Bowel Disease","volume":"37","author":"Ensari","year":"2003","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_76","first-page":"774","article-title":"Is the Lung a Target Organ in Inflammatory Bowel Disease?","volume":"92","author":"Marvisi","year":"2001","journal-title":"Recent. Prog. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0954-6111(89)80132-5","article-title":"Pulmonary Abnormalities in Crohn\u2019s Disease","volume":"83","author":"Neilly","year":"1989","journal-title":"Respir. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.3748\/wjg.v16.i39.4952","article-title":"Pulmonary Involvement in Inflammatory Bowel Disease","volume":"16","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0954-6111(98)90301-8","article-title":"Lung Function in Patients with Inflammatory Bowel Disease","volume":"92","author":"Tzanakis","year":"1998","journal-title":"Respir. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0954-6111(89)80070-8","article-title":"Respiratory Impairment in Inflammatory Bowel Disease: Does It Vary with Disease Activity?","volume":"83","author":"Douglas","year":"1989","journal-title":"Respir. Med."},{"key":"ref_81","first-page":"176","article-title":"Pulmonary and Hematological Alterations in Idiopathic Ulcerative Colitis","volume":"22","author":"Sethy","year":"2003","journal-title":"Indian J. Gastroenterol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4318\/tjg.2011.0215","article-title":"Alterations in the Pulmonary Function Tests of Inflammatory Bowel Diseases","volume":"22","author":"Yalniz","year":"2011","journal-title":"Turk. J. Gastroenterol."},{"key":"ref_83","first-page":"255","article-title":"Pulmonary Function Tests, High-Resolution Computed Tomography Findings and Inflammatory Bowel Disease","volume":"69","author":"Tunc","year":"2006","journal-title":"Acta Gastroenterol. Belg."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1398-9995.1995.tb01214.x","article-title":"Increased Frequency of Bronchial Hyperresponsiveness in Patients with Inflammatory Bowel Disease","volume":"50","author":"Louis","year":"1995","journal-title":"Allergy"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1590\/S0100-879X2005000200007","article-title":"Bronchial Hyperresponsiveness and Analysis of Induced Sputum Cells in Crohn\u2019s Disease","volume":"38","author":"Bartholo","year":"2005","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000068407","article-title":"Bronchial Hyperreactivity and Allergic Status in Inflammatory Bowel Disease","volume":"70","author":"Ceyhan","year":"2003","journal-title":"Respiration"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1053\/rmed.2002.1312","article-title":"Activity Related Increase of Exhaled Nitric Oxide in Crohn\u2019s Disease and Ulcerative Colitis: A Manifestation of Systemic Involvement?","volume":"96","author":"Koek","year":"2002","journal-title":"Respir. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.crohns.2012.09.021","article-title":"Hand-Held Fractional Exhaled Nitric Oxide Measurements as a Non-Invasive Indicator of Systemic Inflammation in Crohn\u2019s Disease","volume":"7","author":"Quenon","year":"2013","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/ibd.21085","article-title":"Value of Fractional Exhaled Nitric Oxide (FE NO) for the Diagnosis of Pulmonary Involvement Due to Inflammatory Bowel Disease","volume":"16","author":"Ozyilmaz","year":"2010","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00408-019-00253-0","article-title":"Elevated Levels of Alveolar Nitric Oxide May Indicate Presence of Small Airway Inflammation in Patients with Inflammatory Bowel Disease","volume":"197","author":"Protopapas","year":"2019","journal-title":"Lung"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3904\/kjim.2014.238","article-title":"Investigation of Pulmonary Involvement in Inflammatory Bowel Disease in an Experimental Model of Colitis","volume":"31","author":"Aydin","year":"2016","journal-title":"Korean J. Intern. Med."},{"key":"ref_92","first-page":"450","article-title":"Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD Study","volume":"26","author":"Biancone","year":"2020","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cgh.2020.08.015","article-title":"The Risk of Extraintestinal Cancer in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Population-Based Cohort Studies","volume":"19","author":"Lo","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/ajg.2013.249","article-title":"Cancer Risk in Inflammatory Bowel Disease According to Patient Phenotype and Treatment: A Danish Population-Based Cohort Study","volume":"108","author":"Jess","year":"2013","journal-title":"Am. J. Gastroenterol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.cgh.2013.03.034","article-title":"Risk of Cancer in Patients with Inflammatory Bowel Diseases: A Nationwide Population-Based Cohort Study with 30 Years of Follow-up Evaluation","volume":"12","author":"Kappelman","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/j.1572-0241.1999.01012.x","article-title":"Increased Risk of Cancer in Ulcerative Colitis: A Population-Based Cohort Study","volume":"94","author":"Leijonmarck","year":"1999","journal-title":"Am. J. Gastroenterol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/gast.2000.16487","article-title":"Hodgkin\u2019s Disease Risk Is Increased in Patients with Ulcerative Colitis","volume":"119","author":"Palli","year":"2000","journal-title":"Gastroenterology"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.chest.2021.12.655","article-title":"Distribution, Risk Factors, and Temporal Trends for Lung Cancer Incidence and Mortality","volume":"161","author":"Huang","year":"2022","journal-title":"Chest"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/ecco-jcc\/jjab052","article-title":"ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease","volume":"15","author":"Kucharzik","year":"2021","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1038\/ajg.2015.284","article-title":"Inflammatory Bowel Disease Patients Are at Increased Risk of Invasive Pneumococcal Disease: A Nationwide Danish Cohort Study 1977\u20132013","volume":"110","author":"Simonsen","year":"2015","journal-title":"Am. J. Gastroenterol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"e417","DOI":"10.1097\/MD.0000000000000417","article-title":"Pneumococcal Vaccination Rates in VHA Patients with Inflammatory Bowel Disease","volume":"94","author":"Case","year":"2015","journal-title":"Medicine"},{"key":"ref_102","first-page":"524","article-title":"Community-Acquired Pneumonia by Legionella Pneumophila. Do We Need to Include New Recommendations for Inflammatory Bowel Disease Patients under Immunomodulators?","volume":"108","year":"2016","journal-title":"Rev. Espa\u00f1ola Enfermedades Dig."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.cgh.2016.04.039","article-title":"Biologic Therapies and Risk of Infection and Malignancy in Patients with Inflammatory Bowel Disease: A Systematic Review and Network Meta-Analysis","volume":"14","author":"Bonovas","year":"2016","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1111\/crj.12726","article-title":"Follow-up of 1887 Patients Receiving Tumor Necrosis-alpha Antagonists: Tuberculin Skin Test Conversion and Tuberculosis Risk","volume":"12","author":"Cagatay","year":"2018","journal-title":"Clin. Respir. J."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/ecco-jcc\/jjw129","article-title":"Negative Screening Does Not Rule Out the Risk of Tuberculosis in Patients with Inflammatory Bowel Disease Undergoing Anti-TNF Treatment: A Descriptive Study on the GETAID Cohort","volume":"10","author":"Abitbol","year":"2016","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1136\/annrheumdis-2015-207319","article-title":"Tuberculosis and Other Opportunistic Infections in Tofacitinib-Treated Patients with Rheumatoid Arthritis","volume":"75","author":"Winthrop","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/ibd\/izy243","article-title":"Increased Risk of Influenza and Influenza-Related Complications Among 140,480 Patients with Inflammatory Bowel Disease","volume":"25","author":"Tinsley","year":"2019","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/gutjnl-2020-322539","article-title":"Effect of IBD Medications on COVID-19 Outcomes: Results from an International Registry","volume":"70","author":"Ungaro","year":"2021","journal-title":"Gut"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1136\/bmj.302.6782.970-a","article-title":"Lung and Skin Hypersensitivity to 5-Aminosalicylic Acid","volume":"302","author":"Saveuse","year":"1991","journal-title":"BMJ"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/00054725-200309000-00004","article-title":"Mesalamine-Related Lung Disease: Clinical, Radiographic, and Pathologic Manifestations","volume":"9","author":"Foster","year":"2003","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1465-9921-13-39","article-title":"Drug-Induced Interstitial Lung Disease: Mechanisms and Best Diagnostic Approaches","volume":"13","author":"Matsuno","year":"2012","journal-title":"Respir. Res."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"136","DOI":"10.5415\/apallergy.2013.3.2.136","article-title":"Acute Eosinophilic Pneumonia Related to a Mesalazine Suppository","volume":"3","author":"Kim","year":"2013","journal-title":"Asia Pac. Allergy"},{"key":"ref_113","first-page":"bcr2013009834","article-title":"Acute Respiratory Failure Secondary to Mesalamine-Induced Interstitial Pneumonitis","volume":"2013","author":"Abraham","year":"2013","journal-title":"Case Rep."},{"key":"ref_114","first-page":"101157","article-title":"Mesalazine-Induced Lung Injury with Severe Respiratory Failure Successfully Treated with Steroids and Non-Invasive Positive Pressure Ventilation","volume":"31","author":"Oi","year":"2020","journal-title":"Respir. Med. Case Rep."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2165\/00003088-197601060-00002","article-title":"Clinical Pharmacokinetics of Sulphasalazine","volume":"1","author":"Das","year":"1976","journal-title":"Clin. Pharmacokinet."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1183\/09031936.02.00267402","article-title":"Sulphasalazine and Lung Toxicity","volume":"19","author":"Parry","year":"2002","journal-title":"Eur. Respir. J."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3748\/wjg.v13.i2.316","article-title":"A Case of Interstitial Pneumonitis in a Patient with Ulcerative Colitis Treated with Azathioprine","volume":"13","author":"Nagy","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/01.mcg.0000225577.81008.ee","article-title":"Severe Pulmonary Toxicity After Azathioprine\/6-Mercaptopurine Initiation for the Treatment of Inflammatory Bowel Disease","volume":"41","author":"Ananthakrishnan","year":"2007","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1586\/1744666X.2013.811173","article-title":"Lung Involvement and Drug-Induced Lung Disease in Patients with Rheumatoid Arthritis","volume":"9","author":"Atzeni","year":"2013","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/rheumatology\/kez337","article-title":"Methotrexate and Interstitial Lung Disease: Controversies and Questions. A Narrative Review of the Literature","volume":"58","author":"Fragoulis","year":"2019","journal-title":"Rheumatology"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1155\/2013\/527912","article-title":"Methotrexate-Induced Pulmonary Toxicity","volume":"20","author":"Jakubovic","year":"2013","journal-title":"Can. Respir. J."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1034\/j.1399-3003.2000.15b25.x","article-title":"Methotrexate Pneumonitis: Review of the Literature and Histopathological Findings in Nine Patients","volume":"15","author":"Imokawa","year":"2000","journal-title":"Eur. Respir. J."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00007611-197903000-00023","article-title":"Methotrexate-Induced Diffuse Interstitial Pulmonary Fibrosis","volume":"72","author":"Bedrossian","year":"1979","journal-title":"S. Med. J."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1001\/archderm.1978.01640240042014","article-title":"Progressive Interstitial Lung Disease from Prolonged Methotrexate Therapy","volume":"114","author":"Kaplan","year":"1978","journal-title":"Arch. Dermatol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0190-9622(87)70052-8","article-title":"Pulmonary Complications Following Methotrexate Therapy","volume":"16","author":"Phillips","year":"1987","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"4","DOI":"10.7861\/futurehealth.6-2-s4","article-title":"Systematic Literature Review Investigating Whether Methotrexate Causes Chronic Pulmonary Fibrosis","volume":"6","author":"Quah","year":"2019","journal-title":"Future Healthc. J."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/ecco-jcc\/jjab178","article-title":"ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment","volume":"16","author":"Raine","year":"2022","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ecco-jcc\/jjz180","article-title":"ECCO Guidelines on Therapeutics in Crohn\u2019s Disease: Medical Treatment","volume":"14","author":"Torres","year":"2020","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_129","first-page":"101012","article-title":"Adalimumab Induced Interstitial Lung Disease","volume":"29","author":"Aqsa","year":"2020","journal-title":"Respir. Med. Case Rep."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.rmed.2009.01.002","article-title":"Pulmonary Complications of Tumor Necrosis Factor-Targeted Therapy","volume":"103","author":"Thavarajah","year":"2009","journal-title":"Respir. Med."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/MAJ.0b013e31824c07e8","article-title":"Infliximab-Induced Nonspecific Interstitial Pneumonia","volume":"344","author":"Sen","year":"2012","journal-title":"Am. J. Med. Sci."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.semarthrit.2010.11.002","article-title":"Interstitial Lung Disease Induced or Exacerbated by TNF-Targeted Therapies: Analysis of 122 Cases","volume":"41","author":"Retamozo","year":"2011","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2169\/internalmedicine.50.4748","article-title":"Adalimumab-Induced Interstitial Pneumonia with an Improvement of Pre-Existing Rheumatoid Arthritis-Associated Lung Involvement","volume":"50","author":"Komiya","year":"2011","journal-title":"Intern. Med."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1590\/S1806-37132014000100012","article-title":"Adalimumab-Induced Acute Interstitial Lung Disease in a Patient with Rheumatoid Arthritis","volume":"40","author":"Dias","year":"2014","journal-title":"J. Bras. Pneumol."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Alaee, S., and Jones, Q. (2018). Case of Drug-Induced Interstitial Lung Disease Secondary to Adalimumab. BMJ Case Rep., 2018.","DOI":"10.1136\/bcr-2018-224375"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.3748\/wjg.v21.i7.2260","article-title":"Adalimumab-Induced Interstitial Pneumonia in a Patient with Crohn\u2019s Disease","volume":"21","author":"Casanova","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3109\/s10165-010-0308-4","article-title":"A Case of Adalimumab-Associated Interstitial Pneumonia with Rheumatoid Arthritis","volume":"20","author":"Yamazaki","year":"2010","journal-title":"Mod. Rheumatol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1155\/2011\/713821","article-title":"A Case of Adalimumab-Induced Pneumonitis in a 45-Year-Old Man with Crohn\u2019s Disease","volume":"18","author":"Reid","year":"2011","journal-title":"Can. Respir. J."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.chest.2018.07.026","article-title":"A 67-Year-Old Man with Psoriatic Arthritis and New-Onset Dyspnea","volume":"154","author":"Phang","year":"2018","journal-title":"Chest"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.autrev.2007.03.003","article-title":"Biological and Clinical Effects of Anti-TNF\u03b1 Treatment","volume":"7","author":"Valesini","year":"2007","journal-title":"Autoimmun. Rev."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MD.0b013e3181441a68","article-title":"Autoimmune Diseases Induced by TNF-Targeted Therapies","volume":"86","author":"Soria","year":"2007","journal-title":"Medicine"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1177\/0961203307080633","article-title":"Letter to the Editor: Infliximab-Induced SLE-like Syndrome Involving the Lung and Pleura","volume":"16","author":"Nugent","year":"2007","journal-title":"Lupus"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1093\/ecco-jcc\/jjac030","article-title":"Efficacy and Safety of Maintenance Ustekinumab for Ulcerative Colitis Through 3 Years: UNIFI Long-Term Extension","volume":"16","author":"Abreu","year":"2022","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1001\/jamadermatol.2018.4118","article-title":"Association of Noninfectious Pneumonia with Ustekinumab Use","volume":"155","author":"Brinker","year":"2019","journal-title":"JAMA Dermatol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1080\/02770903.2020.1827416","article-title":"Ustekinumab Associated Chronic Eosinophilic Pneumonia","volume":"58","author":"Kalra","year":"2021","journal-title":"J. Asthma"},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Despotes, K.A., and Vigeland, C.L. (2022). Stelara Struck: A Case of Noninfectious Pneumonitis Secondary to Ustekinumab. BMC Pulm. Med., 22.","DOI":"10.1186\/s12890-022-02066-z"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.annder.2014.11.004","article-title":"Pneumopathie \u00e0 \u00c9osinophiles Chez Un Patient Atteint de Psoriasis En Plaques Trait\u00e9 Par Ust\u00e9kinumab","volume":"142","author":"Zeboulon","year":"2015","journal-title":"Ann. Dermatol. Venereol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"313","DOI":"10.5152\/TJAR.2017.31967","article-title":"Stop Being So Sensitive: An Exceptionally Rare Report of Ustekinumab-Induced Sub-Acute Hypersensitivity Pneumonitis","volume":"45","author":"Ali","year":"2017","journal-title":"Turk. J. Anesth. Reanim."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/1874306401206010063","article-title":"Drug Induced Interstitial Lung Disease","volume":"6","author":"Schwaiblmair","year":"2012","journal-title":"Open Respir. Med. J."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1684\/ejd.2013.2006","article-title":"Psoriasis Vulgaris Complicated by Eosinophilic Pneumonia during Ustekinumab Treatment","volume":"23","author":"Yashiro","year":"2013","journal-title":"Eur. J. Dermatol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1136\/gutjnl-2015-310022","article-title":"Differential Effects of A4\u03b27 and GPR15 on Homing of Effector and Regulatory T Cells from Patients with UC to the Inflamed Gut in Vivo","volume":"65","author":"Fischer","year":"2016","journal-title":"Gut"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/ecco-jcc\/jjy047","article-title":"Respiratory Tract Infections in Patients with Inflammatory Bowel Disease: Safety Analyses from Vedolizumab Clinical Trials","volume":"12","author":"Feagan","year":"2018","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Marafini, I., Troncone, E., Rocchetti, I., and Monteleone, G. (2021). Respiratory Tract Infections in Inflammatory Bowel Disease Patients Taking Vedolizumab: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.585732"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/eji.201746963","article-title":"Characterization of Mesenchymal Stem\/Stromal Cells with Lymphoid Tissue Organizer Cell Potential in Tonsils from Children","volume":"48","author":"Prados","year":"2018","journal-title":"Eur. J. Immunol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"e1483","DOI":"10.1016\/j.cgh.2021.08.041","article-title":"Drug-Related Pneumonitis in Patients Receiving Vedolizumab Therapy for Inflammatory Bowel Disease","volume":"20","author":"Pugliese","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"e592","DOI":"10.1097\/MJT.0000000000000627","article-title":"Vedolizumab-Associated Acute Respiratory Distress Syndrome","volume":"25","author":"Nambiar","year":"2018","journal-title":"Am. J. Ther."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1053\/j.gastro.2019.09.016","article-title":"New-Onset Diffuse Parenchymal Lung Disease in a 52-Year-Old Woman with Ulcerative Colitis","volume":"158","author":"Bode","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"e1057","DOI":"10.1097\/MEG.0000000000002197","article-title":"Vedolizumab-Induced Acute Interstitial Lung Injury in a 39-Year-Old Male with Ulcerative Colitis","volume":"33","author":"Rizos","year":"2021","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.12998\/wjcc.v10.i5.1716","article-title":"Vedolizumab-Associated Diffuse Interstitial Lung Disease in Patients with Ulcerative Colitis: A Case Report","volume":"10","author":"Zhang","year":"2022","journal-title":"World J. Clin. Cases"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/ajg.2017.395","article-title":"Pulmonary Manifestation of Crohn\u2019s Disease Developed Under Treatment with Vedolizumab","volume":"113","author":"Lissner","year":"2018","journal-title":"Am. J. Gastroenterol."},{"key":"ref_161","first-page":"002265","article-title":"Crohn\u2019s Disease with Atypical Extra-Intestinal Manifestations Developing Under Treatment with Vedolizumab","volume":"8","author":"Cohen","year":"2021","journal-title":"Eur. J. Case Rep. Intern. Med."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1164\/rccm.201806-1056IM","article-title":"Necrobiotic Pulmonary Nodules of Crohn\u2019s Disease in a Patient Receiving Vedolizumab","volume":"199","author":"Myc","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"942237","DOI":"10.3389\/fmed.2022.942237","article-title":"Case Report: Eosinophilic Pneumonia Associated with Vedolizumab Therapy in a Patient with Ulcerative Colitis","volume":"9","author":"Zhu","year":"2022","journal-title":"Front. Med."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/ibd\/izab212","article-title":"Noninfectious Pulmonary Complications Associated with Anti-Integrin Therapy: A Case Report and Systematic Review of the Literature","volume":"28","author":"Dulaney","year":"2022","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11882-021-01018-7","article-title":"Non-IgE-Mediated Drug Hypersensitivity Reactions","volume":"21","author":"Joshi","year":"2021","journal-title":"Curr. Allergy Asthma Rep."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1093\/rheumatology\/keaa117","article-title":"Pulmonary Adverse Events of Small Molecule JAK Inhibitors in Autoimmune Disease: Systematic Review and Meta-Analysis","volume":"59","author":"Khoo","year":"2020","journal-title":"Rheumatology"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2109927","article-title":"Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis","volume":"386","author":"Ytterberg","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/apt.15514","article-title":"Venous Thromboembolic Events in the Tofacitinib Ulcerative Colitis Clinical Development Programme","volume":"50","author":"Sandborn","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/apt.16712","article-title":"Safety and Efficacy of Tofacitinib for Treatment of Ulcerative Colitis: Final Analysis of OCTAVE Open, an Open-label, Long-term Extension Study with up to 7.0 Years of Treatment","volume":"55","author":"Sandborn","year":"2022","journal-title":"Aliment. Pharmacol. Ther."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/19\/6419\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:03:38Z","timestamp":1760130218000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/19\/6419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,9]]},"references-count":169,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["jcm12196419"],"URL":"https:\/\/doi.org\/10.3390\/jcm12196419","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,9]]}}}